Björn H Schott

Dr. Björn H Schott

Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Von Siebold Str 5, D-37075 Goettingen, Germany, German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany, and Leibniz Institute for Neurobiology, Brenneckestr. 6, Magdeburg, Germany
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2005 in Neuron
Verified
Journal Article
Closed access
BWBianca C. Wittmann
Bianca C. Wittmann
BSBjörn H Schott
Björn H Schott
SGSebastian Guderian
Sebastian Guderian
JFJulietta U. Frey
Julietta U. Frey
HHHans-Jochen Heinze
Hans-Jochen Heinze
EDEmrah Düzel
Emrah Düzel

24 December 2008 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
BSBjörn H Schott
Björn H Schott
LMLuciano Minuzzi
Luciano Minuzzi
RKRuth Krebs
Ruth Krebs
DEDavid Elmenhorst
David Elmenhorst
MLMarkus Lang
Markus Lang
ABAndreas Bauer
Andreas Bauer
The dopaminergic mechanisms that control reward-motivated behavior are the subject of intense study, but it is yet unclear how, in humans, neural activity in mesolimbic reward-circuitry and its functional neuroimaging correlates are related to dopamine release. To address this question, we obtained functional magnetic resonance imaging (fMRI) measures of reward-related neural activity and [11C]raclopride positron emission tomography measures of dopamine release in the same human participants, while they performed a delayed monetary incentive task. Across the cohort, a positive correlation emerged between neural activity of the substantia nigra/ventral tegmental area (SN/VTA), the main origin of dopaminergic neurotransmission, during reward anticipation and reward-related [11C]raclopride displacement as an index of dopamine release in the ventral striatum, major target of SN/VTA dopamine neurons. Neural activity in the ventral striatum/nucleus accumbens itself also correlated with ventral striatal dopamine release. Additionally, high-reward-related dopamine release was associated with increased activation of limbic structures, such as the amygdala and the hippocampus. The observed correlations of reward-related mesolimbic fMRI activation and dopamine release provide evidence that dopaminergic neurotransmission plays a quantitative role in human mesolimbic reward processing. Moreover, the combined neurochemical and hemodynamic imaging approach used here opens up new perspectives for the investigation of molecular mechanisms underlying human cognition.

31 March 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SGSebastian Guderian
Sebastian Guderian
BSBjörn H Schott
Björn H Schott
ARAlan Richardson-Klavehn
Alan Richardson-Klavehn
EDEmrah Düzel
Emrah Düzel
We report a human electrophysiological brain state that predicts successful memory for events before they occur. Using magnetoencephalographic recordings of brain activity during episodic memory encoding, we show that amplitudes of theta oscillations shortly preceding the onsets of words were higher for later-recalled than for later-forgotten words. Furthermore, single-trial analyses revealed that recall rate in all 24 participants tested increased as a function of increasing prestimulus theta amplitude. This positive correlation was independent of whether participants were preparing for semantic or phonemic stimulus processing, thus likely signifying a memory-related theta state rather than a preparatory task set. Source analysis located this theta state to the medial temporal lobe, a region known to be critical for encoding and recall. These findings provide insight into state-related aspects of memory formation in humans, and open a perspective for improving memory through theta-related brain states.

1 June 2009 in Trends in Neurosciences
Verified
Journal Article
Closed access
EDEmrah Düzel
Emrah Düzel
NBNico Bunzeck
Nico Bunzeck
MGMarc Guitart-Masip
Marc Guitart-Masip
BWBianca Wittmann
Bianca Wittmann
BSBjörn H Schott
Björn H Schott
PTPhilippe N. Tobler
Philippe N. Tobler

20 June 2017 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
SWStephanie Witt
Stephanie Witt
FSF Streit
F Streit
MJM Jungkunz
M Jungkunz
JFJ Frank
J Frank
SAS Awasthi
S Awasthi
MRM Rietschel
M Rietschel
Borderline personality disorder (BOR) is determined by environmental and genetic factors, and characterized by affective instability and impulsivity, diagnostic symptoms also observed in manic phases of bipolar disorder (BIP). Up to 20% of BIP patients show comorbidity with BOR. This report describes the first case–control genome-wide association study (GWAS) of BOR, performed in one of the largest BOR patient samples worldwide. The focus of our analysis was (i) to detect genes and gene sets involved in BOR and (ii) to investigate the genetic overlap with BIP. As there is considerable genetic overlap between BIP, major depression (MDD) and schizophrenia (SCZ) and a high comorbidity of BOR and MDD, we also analyzed the genetic overlap of BOR with SCZ and MDD. GWAS, gene-based tests and gene-set analyses were performed in 998 BOR patients and 1545 controls. Linkage disequilibrium score regression was used to detect the genetic overlap between BOR and these disorders. Single marker analysis revealed no significant association after correction for multiple testing. Gene-based analysis yielded two significant genes:DPYD(P=4.42 × 10−7) andPKP4(P=8.67 × 10−7); and gene-set analysis yielded a significant finding for exocytosis (GO:0006887,PFDR=0.019; FDR, false discovery rate). Prior studies have implicatedDPYD,PKP4and exocytosis in BIP and SCZ. The most notable finding of the present study was the genetic overlap of BOR with BIP (rg=0.28 [P=2.99 × 10−3]), SCZ (rg=0.34 [P=4.37 × 10−5]) and MDD (rg=0.57 [P=1.04 × 10−3]). We believe our study is the first to demonstrate that BOR overlaps with BIP, MDD and SCZ on the genetic level. Whether this is confined to transdiagnostic clinical symptoms should be examined in future studies.

1 February 2006 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
BSBjörn H Schott
Björn H Schott
CSConstanze I. Seidenbecher
Constanze I. Seidenbecher
DFDaniela B. Fenker
Daniela B. Fenker
CLCorinna J. Lauer
Corinna J. Lauer
NBNico Bunzeck
Nico Bunzeck
EDEmrah Düzel
Emrah Düzel
Recent data from animal studies raise the possibility that dopaminergic neuromodulation promotes the encoding of novel stimuli. We investigated a possible role for the dopaminergic midbrain in human episodic memory by measuring how polymorphisms in dopamine clearance pathways affect encoding-related brain activity (functional magnetic resonance imaging) in an episodic memory task. In 51 young, healthy adults, successful episodic encoding was associated with activation of the substantia nigra. This midbrain activation was modulated by a functional variable number of tandem repeat (VNTR) polymorphism in the dopamine transporter (DAT1) gene. Despite no differences in memory performance between genotype groups, carriers of the (low expressing) 9-repeat allele of the DAT1 VNTR showed relatively higher midbrain activation when compared with subjects homozygous for the 10-repeat allele, who express DAT1 at higher levels. The catechol-O-methyl transferase (COMT) Val108/158Met polymorphism, which is known to modulate enzyme activity, affected encoding-related activity in the right prefrontal cortex (PFC) and in occipital brain regions but not in the midbrain. Moreover, subjects homozygous for the (low activity) Met allele showed stronger functional coupling between the PFC and the hippocampus during encoding. Our finding that genetic variations in the dopamine clearance pathways affect encoding-related activation patterns in midbrain and PFC provides strong support for a role of dopaminergic neuromodulation in human episodic memory formation. It also supports the hypothesis of anatomically and functionally distinct roles for DAT1 and COMT in dopamine metabolism, with DAT1 modulating rapid, phasic midbrain activity and COMT being particularly involved in prefrontal dopamine clearance.